Member of the Board of Directors/Independent director

First appointed to the Board of Directors
Co-option by the Board of Directors (August 27, 2009)
Ratified by the Annual General Meeting (May 7, 2010)

Expiry of term of office
Annual General Meeting to be held in 2026 to approve the financial statements for the year ending December 31, 2025.

Career
• From 1970 to 1996, at Rhône-Poulenc, held the positions of Project Manager, Head of the Asia zone, Chairman and Chief Executive Officer of the Group’s pharmaceutical subsidiary in Indonesia, and Chief Executive Officer of the veterinary subsidiary Rhodia-Mérieux in Brazil and Chief Executive Officer, then Chairman and Chief Executive Officer of Rhône Mérieux France.
• Participated in the creation of Merial in 1997 and was appointed Chairman and Chief Executive Officer until 2000.
• Now retired.

Training
Graduate of IEP Paris.

Current terms of office held in French and foreign companies
None